News Industry News Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT October 22, 2012
News Industry News Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients October 22, 2012
News Industry News STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent October 22, 2012
News Industry News FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study October 22, 2012
News Industry News IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent October 22, 2012
News Conference News TCT 2012 Review of TAVR Use Offers Significant Advances, Positive Outcomes October 22, 2012